EP1455778A4 - Methods for the treatment of peripheral neural and vascular ailments - Google Patents
Methods for the treatment of peripheral neural and vascular ailmentsInfo
- Publication number
- EP1455778A4 EP1455778A4 EP02789474A EP02789474A EP1455778A4 EP 1455778 A4 EP1455778 A4 EP 1455778A4 EP 02789474 A EP02789474 A EP 02789474A EP 02789474 A EP02789474 A EP 02789474A EP 1455778 A4 EP1455778 A4 EP 1455778A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- methods
- peripheral neural
- vascular ailments
- ailments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WOPCT/US01/49297 | 2001-12-19 | ||
PCT/US2001/049297 WO2002049575A2 (en) | 2000-12-21 | 2001-12-19 | Method and composition for the treatment of diabetic neuropathy |
PCT/US2002/035654 WO2003053336A2 (en) | 2001-12-19 | 2002-11-06 | Methods for the treatment of peripheral neural and vascular ailments |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1455778A2 EP1455778A2 (en) | 2004-09-15 |
EP1455778A4 true EP1455778A4 (en) | 2007-09-12 |
Family
ID=21743140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02789474A Withdrawn EP1455778A4 (en) | 2001-12-19 | 2002-11-06 | Methods for the treatment of peripheral neural and vascular ailments |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1455778A4 (en) |
JP (1) | JP2005518381A (en) |
CA (1) | CA2470603A1 (en) |
IL (1) | IL162505A0 (en) |
MX (1) | MXPA04006039A (en) |
NZ (1) | NZ533439A (en) |
WO (1) | WO2003053336A2 (en) |
ZA (1) | ZA200404614B (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2543404A1 (en) * | 2003-10-24 | 2005-05-06 | Meiji Seika Kaisha, Ltd. | Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor |
CA2543676C (en) * | 2003-10-30 | 2011-04-26 | Meiji Seika Kaisha, Ltd. | Tyrosinase activity inhibitor and ameliorant for facial blood flow |
EP1684774B1 (en) * | 2003-11-05 | 2012-08-29 | Osteoscreen, Inc. | Stimulation of hair growth by isoginkgetin |
JP2006083105A (en) * | 2004-09-16 | 2006-03-30 | Ito En Ltd | Ameliorant for blood fluidity and food and beverage |
JP2008546845A (en) * | 2005-06-28 | 2008-12-25 | ケージーケー シナガイズ インク. | Compositions that improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease |
DE102005048778A1 (en) * | 2005-10-10 | 2007-04-12 | Beiersdorf Ag | Cosmetic formulations to improve the appearance of the skin |
DE102005048777A1 (en) * | 2005-10-10 | 2007-04-12 | Beiersdorf Ag | Cosmetic formulations to improve the microcirculation of the skin |
JP5132889B2 (en) * | 2006-02-27 | 2013-01-30 | 株式会社ポッカコーポレーション | Nerve growth factor potentiator |
SG170828A1 (en) * | 2006-04-05 | 2011-05-30 | Vertex Pharmaceuticals Inc Us | Deazapurines useful as inhibitors of janus kinases |
FR2904557B1 (en) * | 2006-08-01 | 2010-04-30 | Pf Medicament | NOVEL EUCALYPTUS EXTRACT, PREPARATION METHOD THEREOF AND THERAPEUTIC USES THEREOF |
GB0618168D0 (en) * | 2006-09-15 | 2006-10-25 | Babraham Inst | Compounds |
US20090060879A1 (en) * | 2007-09-04 | 2009-03-05 | The Procter & Gamble Company | Oral Compositions, Products and Methods Of Use |
AU2009274571A1 (en) * | 2008-07-23 | 2010-01-28 | Massachusetts Institute Of Technology | Activation of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival |
JP5415216B2 (en) * | 2009-10-02 | 2014-02-12 | 日本メナード化粧品株式会社 | Topical skin preparation |
CN102266320B (en) * | 2010-07-20 | 2015-06-17 | 浙江养生堂天然药物研究所有限公司 | New application of hesperetin |
KR101021835B1 (en) | 2010-09-06 | 2011-03-17 | 충남대학교산학협력단 | A composition comprising chrysosplenol c for treating and preventing heart disease |
CN102151281B (en) * | 2011-01-24 | 2014-03-26 | 中国药科大学 | Flavonoid compound for preventing and treating diabetes and medicament application thereof |
WO2013016193A2 (en) | 2011-07-22 | 2013-01-31 | Massachusetts Istitute Of Technology | Activators of class i histone deacetlyases (hdacs) and uses thereof |
NZ596015A (en) * | 2011-10-26 | 2014-04-30 | Anzamed Internat Ltd | Method and composition for the treatment of pain and/or inflammation |
CN102526248B (en) * | 2012-03-22 | 2013-07-17 | 赵海潞 | Traditional Chinese medicine prescription capable of curing diabetes wound fester and continuously reducing blood sugar |
US20180193306A1 (en) | 2012-03-23 | 2018-07-12 | Cardero Therapeutics, Inc. | Compounds and compositions for the treatment of muscular disorders and bone disorders |
WO2013142816A1 (en) * | 2012-03-23 | 2013-09-26 | Cardero Therapeutics, Inc. | Compounds and compositions for the treatment of muscular disorders |
ITRM20120335A1 (en) * | 2012-07-13 | 2014-01-14 | Aboca Spa Societa Agricola | NEW COMPOSITIONS FOR NEUROPATHIC PAIN TREATMENT. |
WO2014095289A2 (en) * | 2012-12-20 | 2014-06-26 | Unilever Plc | Method of treating hair ageing |
BR112015023031A2 (en) | 2013-03-15 | 2017-07-18 | Abbott Lab | methods of conservation and improvement of muscle function |
CN104547872A (en) * | 2015-01-30 | 2015-04-29 | 山东省立医院 | Traditional Chinese medicine composition for treating epilepsy |
CN107126437A (en) * | 2016-02-29 | 2017-09-05 | 上海中医药大学 | A kind of medicinal usage of Sophoricoside |
KR101828379B1 (en) | 2016-03-30 | 2018-02-12 | 우석대학교 산학협력단 | Compositions for the improvement of memory and cognition ability, or prevention, delay, improvement or treatment of Alzheimer's disease comprising Rosa rugosa THUNB flower extracts or fractions |
KR101715294B1 (en) * | 2016-06-09 | 2017-03-10 | 연세대학교 산학협력단 | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising diosmin or salt thereof |
WO2018078412A1 (en) * | 2016-10-31 | 2018-05-03 | Posi Visionary Solutions Llp | Topical microemulsion of diosmetin and uses thereof |
CN108164489B (en) * | 2018-03-20 | 2019-11-26 | 武汉轻工大学 | A kind of preparation method of Galangin |
BR102018005599A2 (en) * | 2018-03-21 | 2019-10-08 | Pedro Barboza Da Rocha | HAZARDOUS, HYDRATING, MOISTURIZING AND EMOLIENT COMPOSITION FOR TOPIC ADMINISTRATION IN INTERTRIGO SKIN INJURIES, SKIN INJURY AND FECAL INJURY AND OTHER RELATED INJURY. |
WO2020051644A1 (en) * | 2018-09-13 | 2020-03-19 | Norbio No. 2 Pty Ltd | Treatment of peripheral nervous tissue inflammation |
CN112014480B (en) * | 2019-05-28 | 2023-03-28 | 黄河科技学院 | Method for detecting content of effective components in Jiangzhining granules by UPLC-MS/MS |
WO2022157381A1 (en) * | 2021-01-25 | 2022-07-28 | Universiteit Hasselt | Phloretin for use in the treatment of neurodegenerative and demyelinating diseases |
CN115317497A (en) * | 2022-01-13 | 2022-11-11 | 宁夏医科大学 | Application of liquiritin in preparing thoracic aorta vasodilation medicine |
CN114392256B (en) * | 2022-02-22 | 2023-05-09 | 中山大学附属第八医院(深圳福田) | Application of cyanidin in preventing and treating vascular calcification |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076580A1 (en) * | 2000-04-11 | 2001-10-18 | Takara Bio Inc. | Remedies |
WO2002049575A2 (en) * | 2000-12-21 | 2002-06-27 | The Quigley Corporation | Method and composition for the treatment of diabetic neuropathy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03232851A (en) * | 1989-12-26 | 1991-10-16 | Nippon Flour Mills Co Ltd | Aldose reductase inhibitor |
JPH09235284A (en) * | 1995-02-23 | 1997-09-09 | Nissan Chem Ind Ltd | Indole-type thiazolidine compound |
IT1291113B1 (en) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS |
IT1302307B1 (en) * | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | COMPOSITION WITH ANTIOXIDANT ACTIVITY AND FOR IMPROVING THE METABOLIC USE OF GLUCOSE, INCLUDING ACETYL |
JP4497566B2 (en) * | 1998-09-02 | 2010-07-07 | 株式会社 日本薬用食品研究所 | Aldose reductase inhibitors and novel saponins and novel sapogenols |
-
2002
- 2002-11-06 WO PCT/US2002/035654 patent/WO2003053336A2/en active IP Right Grant
- 2002-11-06 NZ NZ533439A patent/NZ533439A/en not_active IP Right Cessation
- 2002-11-06 EP EP02789474A patent/EP1455778A4/en not_active Withdrawn
- 2002-11-06 JP JP2003554096A patent/JP2005518381A/en active Pending
- 2002-11-06 IL IL16250502A patent/IL162505A0/en not_active IP Right Cessation
- 2002-11-06 CA CA002470603A patent/CA2470603A1/en not_active Abandoned
- 2002-11-06 MX MXPA04006039A patent/MXPA04006039A/en active IP Right Grant
-
2004
- 2004-06-10 ZA ZA200404614A patent/ZA200404614B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076580A1 (en) * | 2000-04-11 | 2001-10-18 | Takara Bio Inc. | Remedies |
EP1283037A1 (en) * | 2000-04-11 | 2003-02-12 | Takara Bio Inc. | Remedies |
WO2002049575A2 (en) * | 2000-12-21 | 2002-06-27 | The Quigley Corporation | Method and composition for the treatment of diabetic neuropathy |
Non-Patent Citations (3)
Title |
---|
SCHOEMAKER J H: "PHARMACOLOGICAL TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY: CHALLENGES AND POSSIBILITIES", BRITISH JOURNAL OF CLINICAL PRACTICE, vol. 48, no. 2, 1994, pages 91 - 96, XP000878610, ISSN: 0007-0947 * |
See also references of WO03053336A2 * |
VARMA ET AL: "Flavonoids as Inhibitors of lens Aldose reductase.", SCIENCE, vol. 188, 1995 - 1995, pages 1215 - 1216, XP002431692 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003053336A3 (en) | 2003-11-27 |
MXPA04006039A (en) | 2004-09-27 |
AU2002352501A1 (en) | 2003-07-09 |
IL162505A0 (en) | 2005-11-20 |
NZ533439A (en) | 2006-06-30 |
EP1455778A2 (en) | 2004-09-15 |
CA2470603A1 (en) | 2003-07-03 |
ZA200404614B (en) | 2005-08-29 |
JP2005518381A (en) | 2005-06-23 |
WO2003053336A2 (en) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1455778A4 (en) | Methods for the treatment of peripheral neural and vascular ailments | |
AU7186501A (en) | Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases | |
WO2002086502A8 (en) | Methods for the diagnosis and treatment of bone disorders | |
EP1416961A4 (en) | Composition and method for the treatment of disease | |
PL366636A1 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
EP1509279A4 (en) | Device and method for the treatment of cardiac disorders | |
EP1360965A4 (en) | Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases | |
HU0200493D0 (en) | Method for the treatment of nuclear factor-kappa b mediated diseases and disorders | |
SI1487541T1 (en) | Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases | |
HUP0400005A3 (en) | Use of osteopontin for the treatment and/or prevention of neurologic diseases | |
AU2002339128A1 (en) | Use of reelin, gas6, and protein s in the treatment of neural disorders | |
EP1191941A4 (en) | A method for the prophylaxis and/or treatment of medical disorders | |
HUP0400119A3 (en) | Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite | |
HUP0303306A3 (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease | |
EP1377287A4 (en) | Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases | |
GB0128674D0 (en) | Treatment of sleep disorders and the like | |
HUP0401913A3 (en) | Medicine for preventing and treating bromhidrosis | |
EP1539100A4 (en) | Composition and methods for the treatment of skin disorders | |
AU6274101A (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
GB0111441D0 (en) | Method and kit for the treatment of cosmetic skin conditions | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2002365654A8 (en) | Treatment of diseases via the skin | |
SI1392292T1 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
AU2728301A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2001279720A1 (en) | Agent for the external treatment of pain and skin disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040609 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070813 |
|
17Q | First examination report despatched |
Effective date: 20090317 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20101108 |